BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35155208)

  • 1. Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.
    Tian J; Zeng X; Wan J; Gan J; Ke C; Guan W; Hu Z; Yang C
    Front Oncol; 2021; 11():819098. PubMed ID: 35155208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
    Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
    Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis.
    Liu Z; Yang Z; Li J; Liu Z; Ma N; Chen P; Bi X; Li Z; Dong P; Han H; He X; Mao X; Guo S
    Asian J Surg; 2023 Sep; 46(9):3607-3613. PubMed ID: 37147255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis.
    Srivastava A; Patel HD; Joice GA; Semerjian A; Gorin MA; Johnson MH; Allaf ME; Pierorazio PM
    Urol Oncol; 2018 Jan; 36(1):12.e7-12.e13. PubMed ID: 28970053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
    Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
    Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
    Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
    Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis for comparison of partial nephrectomy
    Liu H; Kong QF; Li J; Wu YQ; Pan KH; Xu B; Wang YL; Chen M
    Transl Androl Urol; 2021 Mar; 10(3):1170-1178. PubMed ID: 33850752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
    Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
    Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis.
    Deng H; Fan Y; Yuan F; Wang L; Hong Z; Zhan J; Zhang W
    Int Braz J Urol; 2021; 47(1):46-60. PubMed ID: 32271510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1-2M1 renal cell carcinoma.
    Tian J; Zeng X; Zhu J; Guan W; Hu Z; Yang C
    Transl Cancer Res; 2023 Feb; 12(2):301-309. PubMed ID: 36915574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis.
    Veys R; Abdollah F; Briganti A; Albersen M; Poppel HV; Joniau S
    Cent European J Urol; 2018; 71(1):48-57. PubMed ID: 29732207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
    Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
    J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
    Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
    Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinoma.
    Hu X; Wang Y; Shao Y; Wu K; Tang Y; Ren S; Li X
    Eur J Surg Oncol; 2023 Aug; 49(8):1519-1523. PubMed ID: 36958950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial versus radical nephrectomy for T1b-2N0M0 renal tumors: A propensity score matching study based on the SEER database.
    Zhang M; Zhao Z; Duan X; Deng T; Cai C; Wu W; Zeng G
    PLoS One; 2018; 13(2):e0193530. PubMed ID: 29489911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.